AZN vs NSIT · P/E 28, $288.38B cap vs P/E 28, rev $4.53B
AstraZeneca PLC (AZN) versus Insight Enterprises Inc (NSIT) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Insight Enterprises Inc (NSIT) is a electronics & computer distribution company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported NSIT revenue for 2026-06-30 was $4.53B. Net income was $107.6M. NSIT currently screens at market cap $4.47B and trailing P/E 27.8.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NSIT currently screens at market cap $4.47B and trailing P/E 27.8.
Not investment advice. Open the AZN and NSIT stock pages for the full models.
Not investment advice.